Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

FLGT stock hub

Fulgent Genetics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FLGTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

453.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

FLGT

In the news

Latest news · FLGT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-6.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-13

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FLGT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001674930
Company name	Fulgent Genetics, Inc.
Country	United States
Country code	US
Cusip	359664109
Employees	1,315
Employees Change	2%
Employees Change Percent	0.15
Enterprise value	$-141.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2016-09-29
Isin	US3596641098
Last refreshed	2026-05-10
Market cap	$453.3M
Market cap category	Small-Cap
Price	$15.96
Price currency	USD
Rev Per Employee	243,609.13x
Sector	Healthcare
Sic	8071
Symbol	FLGT
Website	https://www.fulgentgenetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.28%
FCF yield	-24.97%
P/B ratio	0.44x
P/S ratio	1.41x
PS Forward	1.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-31.65%
EBITDA Margin	-24.1%
Gross margin	38.71%
Gross Profit	$124M
Gross Profit Growth	9.31%
Gross Profit Growth Q	-24.19%
Gross Profit Growth3 Y	-4.67%
Gross Profit Growth5 Y	-27.37%
Net Income	$-73.8M
Net Income Growth Years	0%
Pretax Margin	-26.31%
Profit Margin	-23.04%
Profit Per Employee	$-56,129
ROA	-5.37
Roa5y	7.85
ROCE	-9.51
ROE	-6.92
Roe5y	9.21
ROIC	-13.03
Roic5y	17.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-14.43%
Cagr3y	-22.22%
Cagr5y	-26.55%
EPS Growth Years	0
Revenue Growth	9.54x
Revenue Growth Q	-3.17x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.25x
Revenue Growth5 Y	-16.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.27
Assets	$1.2B
Cash	$276.3M
Current Assets	$479M
Current Liabilities	$90.1M
Debt	$10.2M
Debt Equity	$0.01
Equity	$1B
Interest Coverage	-1,300
Liabilities	$112.2M
Long Term Assets	$677.3M
Long Term Liabilities	$22.1M
Net Cash	$594.4M
Net Cash By Market Cap	$131
Net Cash Growth	-26.26%
Net Debt Equity	$-0.57
Tangible Book Value	$842.1M
Tangible Book Value Per Share	$29.19
WACC	8.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.31
Net Working Capital	$115.3M
Quick ratio	3.91
Working Capital	$388.9M
Working Capital Turnover	$0.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.95%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-14.42%
200-day SMA	22.11
3Y total return	-52.96%
50-day SMA	15.42
50-day SMA vs 200-day SMA	50under200
5Y total return	-78.62%
All Time High	189.9
All Time High Change	-91.6%
All Time High Date	2021-02-09
All Time Low	2.73
All Time Low Change	485.69%
All Time Low Date	2017-11-07
ATR	0.72
Beta	0.88
Beta1y	0.55
Beta2y	0.39
Ch YTD	-39.25
High	15.97
High52	31.04
High52 Date	2025-11-25
High52ch	-48.58%
Low	14.94
Low52	13.46
Low52 Date	2026-03-03
Low52ch	18.57%
Ma50ch	3.48%
Premarket Change Percent	-0.73
Premarket Price	$15
Premarket Volume	7,654
Price vs 200-day SMA	-27.8%
RSI	52.32
RSI Monthly	40.6
RSI Weekly	38.34
Sharpe ratio	-0.02x
Sortino ratio	0.07
Total Return	-0.95%
Tr YTD	-39.25
Tr1m	0.31%
Tr1w	12.95%
Tr3m	-31.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$15
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.38
Earnings Revenue Estimate	68,154,384x
Earnings Revenue Estimate Growth	-7.23x
Operating Income	$-101.4M
Operating margin	-31.65
Price target	$22.5
Price Target Change	$40.98
Price Target Change Top	$-6.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,733,277%
Float Percent	62.44%
Net Borrowing	-828,000
Shares Insiders	37.56%
Shares Institutions	63.78%
Shares Out	28,400,623
Shares Qo Q	-0.32%
Shares Yo Y	0.95%
Short Float	14.99%
Short Ratio	4.19
Short Shares	9.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-152.1M
Average Volume	568,985.85x
Bv Per Share	36.39
CAPEX	$-23.1M
Ch1m	0.31
Ch1w	12.95
Ch1y	-14.42
Ch3m	-31.91
Ch3y	-52.96
Ch5y	-78.62
Ch6m	-39.45
Change	5.63%
Change From Open	6.61
Close	15.11
Days Gap	-0.93
Depreciation Amortization	24,204,000
Dollar Volume	12,094,488
Earnings Date	2026-05-01
Earnings Time	bmo
EBIT	$-101.4M
EBITDA	$-77.2M
EPS	$-2.4
F Score	2
FCF	$-113.2M
FCF EV Yield	80.18x
FCF Per Share	$-3.98
Financing CF	-48,450,000
Fiscal Year End	December
Founded	2,011
Goodwill	53,731,000
Income Tax	$-9.3M
Investing CF	94,581,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-01
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-27
Ma150	22.4
Ma150ch	-28.75%
Ma20	15.58
Ma20ch	2.42%
Net CF	-43,882,000
Next Earnings Date	2026-07-31
Open	14.97
Optionable	Yes
Position In Range	99.03
Post Close	15.96
Postmarket Change Percent	-1
Postmarket Price	$15.8
Ppne	124,285,000
Pre Close	15.11
Price Date	2026-05-08
Ptbv Ratio	0.54
Relative Volume	1.33x
Revenue	320,346,000x
SBC By Revenue	12.15x
Share Based Comp	38,922,000
Tax By Revenue	-2.89x
Tr6m	-39.45%
Us State	California
Volume	757,800
Z Score	4.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FLGT pay a dividend?

Capital-return profile for this ticker.

Performance

FLGT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FLGT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.8%

Float: +62.4% of shares outstanding

Insider ownership

+37.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FLGT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.3

Neutral momentum band

Price vs 200-day MA

-27.8%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

-0.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FLGT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current FLGT stock rating?

Fulgent Genetics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full FLGT analysis?

The full report lives at /stocks/FLGT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for FLGT?

The latest report frames FLGT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the FLGT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.